Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 25, 2025
Hovione and Microinnova Engineering announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry.
read more
Hovione and Merrion Pharmaceuticals [ESM; MERR] announced today that they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione clients. Hovione, an international contract ...
read more
Wednesday, March 22, 2023
Hovione and Laxxon Medical announced a collaboration to advance the use of 3D screen printing technologies for the pharma industry.
read more
Hovione, a provider of spray drying and particle engineering services, announced an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
read more
Hovione was a founding member of iBET in 1989 and has just re-joined the Instituto de Biologia Experimental e Tecnológica. In order to increase the scope and strength of its research and development programs in the areas of novel and high potential ...
read more
Hovione and Firstgene Life Sciences announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC), a therapeutic indication developed by ...
read more
The House on Tuesday approved a bipartisan bill that would update regulation of harmful chemicals for the first time in nearly 40 years.
read more
Hoth Therapeutics has signed contracts with providers for production of their BioLexa therapeutic, in preparation for upcoming toxicology and clinical studies.
read more
Hoth Therapeutics, a patient-focused biopharmaceutical company, announced that it has received approval from the FDA for a protocol change in its Phase 2a clinical trial of HT-001.
read more
Wednesday, March 25, 2020
Hoth has reached an agreement with Voltron to form a joint venture entity to commence preclinical studies for the development of vaccine prospects to prevent, intercept or treat the COVID-19.
read more
Hoth has executed an agreement with Reprocell to assess the effect of the HT-003 therapeutic platform on tissue from ulcerative colitis and Crohn's disease patients.
read more
Hoth reached an agreement with Voltron to form a joint venture entity to commence preclinical studies for the development of vaccine prospects to prevent the COVID-19.
read more
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced an important milestone, commemorating five years of providing biosimilars to the European market and delivery of more than five ...
read more
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and...
read more
Wednesday, April 01, 2020
Horizon Discovery and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.
read more